Anagliptin (SK-0403): From DPP-4 to Vascular Biology
2026-08-19
Anagliptin (SK-0403) offers translational researchers a way to connect incretin biology with direct vascular physiology. This article examines its DPP-4 inhibition mechanism, the evidence for Kv channel modulation and SERCA pump regulation, and practical strategies for advancing vasorelaxant mechanism research beyond a conventional product-page narrative.
Talabostat mesylate (PT-100) for FAP Tumor Assays
2026-08-19
Talabostat mesylate, also known as PT-100, gives researchers a practical pharmacological tool for separating DPP4 and FAP biology in tumor, immune, and stromal models. This guide translates FAP-focused vascular research into reproducible workflows, control strategies, and troubleshooting steps without equating enzyme inhibition with direct antitumor efficacy.
SHC-1 Inhibition and CFTR Surface Trafficking
2026-08-18
Barros and colleagues show that MAPK/SHC-1-dependent CFTR internalization is conserved across airway and intestinal epithelial models, but pharmacological SHC-1 inhibition increases surface CFTR only in CFBE cells. The study’s key contribution is its emphasis on cell-context dependence and unrelated plasma membrane controls when evaluating CFTR trafficking interventions.
ARID1A-Dependent Resistance in Melanoma Multi-Omics
2026-08-18
This study integrates transcriptomic, protein-level, and signaling data to define how ARID1A loss rewires melanoma responses to BRAF/MAPK inhibition. Its identification of PRKD1, JUN, and NCK1 as resistance-associated network nodes provides a mechanistic framework for studying adaptive signaling, immune-evasion features, and therapeutic failure.
Antipyrine in BBB Assays: Measuring Flux and Fate
2026-08-17
Antipyrine can strengthen blood-brain barrier assay interpretation when permeability, efflux, and intracellular recovery are analyzed together. This guide translates a 2025 surrogate BBB study into practical decisions for pharmacokinetic studies, dose preparation, and mass-balance control.
ARCA Cy5 EGFP mRNA (5-moUTP): Assay Design
2026-08-16
ARCA Cy5 EGFP mRNA (5-moUTP) enables researchers to separate cellular uptake from productive translation in mammalian-cell delivery studies. This guide turns dual fluorescence into a rigorous framework for evaluating macrophage-targeted nanoparticles, localization, and transfection performance.
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-15
Zhao and colleagues present a standardized fresh whole-blood stimulation protocol that combines immune challenges with pharmacological metabolism modulation and cytokine quantification. The framework improves comparability across cohort studies while showing that anabolic and catabolic pathway interventions can selectively reshape immune-cell cytokine output.
AM 281: CB1 Antagonist Workflow for Brain Research
2026-08-15
AM 281 provides a receptor-level tool for separating CB1 signaling from upstream endocannabinoid changes in TBI, addiction, and memory assays. This workflow combines controlled formulation, time-resolved tissue collection, behavioral testing, and orthogonal pathway readouts to improve mechanistic confidence.
YM-155 Hydrochloride: From Assay to Translation
2026-08-14
A translational framework for using YM-155 hydrochloride as a selective survivin inhibitor while distinguishing proliferation arrest from true cell killing, strengthening model selection, assay design, and preclinical decision-making.
Tiamulin Metabolites Across Farm Animal Species
2026-08-14
The reference study mapped tiamulin biotransformation across rats, chickens, swine, goats, and cows using UHPLC–quadrupole/time-of-flight mass spectrometry. Its comparative metabolite profiles identify species-dependent pathways and refine potential marker residues for residue surveillance, especially in chickens and swine.
N4-Acetylcytidine Workflow Guide
2026-08-13
N4-Acetylcytidine enables controlled studies of free ac4C nucleoside metabolism, enzyme substrate specificity, and analytical assay performance. This guide distinguishes those use cases from experiments on RNA-incorporated ac4C, with practical preparation, controls, and troubleshooting strategies.
EZ Cap™ OVA mRNA for Immune Modeling
2026-08-13
Use EZ Cap™ OVA mRNA as a defined model-antigen payload for comparing delivery systems, expression conditions, and immune readouts. Its Cap 1 structure and poly(A) tail support reproducible Ovalbumin mRNA expression while enabling practical studies of carrier-associated inflammation.
SGLT2 Cardioprotection: Class Effect or Drug Effect?
2026-08-12
A 2022 mouse study directly compared empagliflozin, dapagliflozin, and ertugliflozin in non-diabetic myocardial ischemia/reperfusion injury. Although all three compounds produced comparable urinary glucose excretion at stoichiometrically equivalent doses, only empagliflozin and dapagliflozin reduced infarct size, implicating drug-specific STAT-3 and PI3K-linked mechanisms rather than SGLT2 inhibition alone.
Equine Salmonella: TMP–Sulfonamide Synergy
2026-08-12
This 1994 study tested trimethoprim and nine sulfonamides against 62 Salmonella strains recovered from horses, using agar dilution and fractional inhibitory concentration analysis. It identified sulfadiazine, sulfachlorpyridazine, and sulfamethoxazole as the most useful partners for trimethoprim, while also showing that resistance patterns varied substantially among isolates.
Vitamin C, ROS/NF-κB, and Cochlear Cell Senescence
2026-08-11
A 2024 Molecular Biology Reports study used D-galactose-treated HEI-OC1 cochlear hair cells to show that vitamin C reduces senescence-associated changes alongside suppression of ROS accumulation and NF-κB activation. N-acetyl-L-cysteine served as a redox-oriented comparator, strengthening the interpretation that oxidative stress pathway modulation contributes to the protective phenotype while leaving in vivo hearing restoration unresolved.
460 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page